Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Ryosuke Hirohata
Yoichi Hamai
Jun Hihara
Manabu Emi
Tomoaki Kurokawa
Toru Yoshikawa
Manato Ohsawa
Nao Kitasaki
Morihito Okada
机构：
[1] Hiroshima University,Department of Surgical Oncology
来源：
World Journal of Surgery | 2022年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1934 / 1943
页数：9
相关论文
共 50 条
  • [41] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [42] Chemoradiotherapy followed by surgery could improve the efficacy of treatments in patients with resectable esophageal carcinoma
    Wang Feng
    Wang Ya-mei
    He Wei
    Li Xiang-ke
    Peng Fang-hui
    Yang Xiao-li
    Fan Qing-xia
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (16) : 3138 - 3145
  • [43] Clinical Outcomes of Intra-arterial Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Followed by Surgery for Maxillary Sinus Squamous Cell Carcinoma
    Yunaiyama, Daisuke
    Tsukahara, Kiyoaki
    Okubo, Mitsuro
    Saito, Kazuhiro
    [J]. IRANIAN JOURNAL OF RADIOLOGY, 2021, 18 (03)
  • [44] Induction chemotherapy with TPF followed by chemoradiotherapy for esophageal squamous cell carcinoma
    Ariga, H.
    Kikuchi, K.
    Iwaya, T.
    Oikawa, H.
    Kakuhara, H.
    Segawa, T.
    Yamaguchi, S.
    Nakamura, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S401 - S402
  • [45] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [46] Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma
    Kawai, Takaharu
    Kochi, Mitsugu
    Fujii, Masashi
    Song, Keio
    Hagiwara, Ken
    Watanabe, Megumu
    Matsuno, Yoritaka
    Suda, Hiroshi
    Yagi, Renpei
    Takayama, Tadatoshi
    [J]. ANTICANCER RESEARCH, 2017, 37 (06) : 3301 - 3306
  • [47] Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma
    Nakashima, Yuichiro
    Saeki, Hiroshi
    Hu, Qingjiang
    Tsuda, Yasuo
    Hisamatsu, Yuichi
    Ando, Koji
    Oki, Eiji
    Maehara, Yoshihiko
    [J]. ANTICANCER RESEARCH, 2018, 38 (12) : 6809 - 6814
  • [48] Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
    Wen, Jing
    Fang, Shuogui
    Hu, Yi
    Xi, Mian
    Weng, Zelin
    Pan, Chuqing
    Luo, Kongjia
    Ling, Yihong
    Lai, Renchun
    Xie, Xiuying
    Lin, Xiaodan
    Lin, Ting
    Chen, Jiyang
    Liu, Qianwen
    Fu, Jianhua
    Yang, Hong
    [J]. EBIOMEDICINE, 2022, 86
  • [49] Converting borderline-resectable, locally-advanced esophageal carcinoma to resectability with neoadjuvant chemoradiotherapy.
    Horne, Zachary D.
    Sun, Weijing
    Gibson, Michael K.
    Pennathur, Arjun
    Luketich, James D.
    Karlovits, Brian J.
    Heron, Dwight Earl
    Greenberger, Joel S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [50] Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
    Kitasaki, Nao
    Hamai, Yoichi
    Emi, Manabu
    Kurokawa, Tomoaki
    Yoshikawa, Toru
    Hirohata, Ryosuke
    Ohsawa, Manato
    Okada, Morithito
    [J]. IN VIVO, 2022, 36 (06): : 2852 - 2860
12345